Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Kejal Amin"'
Autor:
Annette Hood, Blerina Mukallari, Jacqueline Majeski, Lajos Pusztai, Kerin Adelson, Kejal Amin
Publikováno v:
Journal of the National Comprehensive Cancer Network. 21:BPI23-012
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c533d935f2e9fde4e0645aab10fde61a
https://doi.org/10.6004/jnccn.2022.7224
https://doi.org/10.6004/jnccn.2022.7224
Autor:
Robert D Bona, Craig Keating, Alfred Ian Lee, Donna Neuberg, Nicholas DeFilippo, Jonathan M. Siner, Matthew L Meizlish, Yuxin Liu, Stephen Wang, Kent A. Owusu, Dayna McManus, Rebecca S. Fine, Michael Mankbadi, George Goshua, Cassius Iyad Ochoa Chaar, Eric Chang, Christina Price, Hyung J. Chun, Alexander B Pine, Henry M. Rinder, Yiwen Liu, Kejal Amin
Publikováno v:
American Journal of Hematology
BackgroundThrombotic complications occur at high rates in hospitalized patients with COVID-19, yet the impact of intensive antithrombotic therapy on mortality is uncertain.Research QuestionHow does in-hospital mortality compare with intermediate-vers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3b6eede029da4963b28c5e0e1331608
https://doi.org/10.1002/ajh.26102
https://doi.org/10.1002/ajh.26102
Autor:
Kejal Amin, Jessica Shank Coviello
Publikováno v:
Journal of the Advanced Practitioner in Oncology
Cardio-oncology is a rapidly emerging field, and advanced practitioners (APs) play key roles in the prevention, early detection, and optimal treatment of cardiotoxicities associated with cancer therapies. At JADPRO Live Virtual 2020, Jessica Shank Co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b05075d610e6f0cbb1e280a35f27f55
https://doi.org/10.6004/jadpro.2021.12.3.6
https://doi.org/10.6004/jadpro.2021.12.3.6
Publikováno v:
Blood Rev
FLT3 mutations are the most common genetic aberrations found in acute myeloid leukemia (AML) and associated with poor prognosis. Since the discovery of FLT3 mutations and their prognostic implications, multiple FLT3-targeted molecules have been evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::417453d0e62c3b06cc0ca52b136ab143
https://doi.org/10.1016/j.blre.2021.100905
https://doi.org/10.1016/j.blre.2021.100905
Autor:
George Goshua, Yiwen Liu, Matthew L. Meizlish, Rebecca Fine, Kejal Amin, Eric Chang, Yuxin Liu, Dayna McManus, Adina Petrosan, Cassius Ilya Ochoa Chaar, Hyung J. Chun, Nicholas A. Defilippo, Donna S. Neuberg, Kent A. Owusu, Alfred Ian Lee
Publikováno v:
Blood
Introduction: Venous thromboembolism and in-situ small vessel thrombosis are increased in hospitalized patients with COVID-19 in several patient cohorts. Endotheliopathy and activation of both platelets and coagulation predict critical illness and de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f5b8e8e5fe157bafb798d27d7a05d37
http://europepmc.org/articles/PMC8330288
http://europepmc.org/articles/PMC8330288
Autor:
Rachael Gerstein, Molly Schiffer, Kejal Amin, Tarsheen K. Sethi, Sonal Agarwal, Francine M. Foss
Publikováno v:
Blood. 138:4547-4547
Background: T-cell lymphomas constitute heterogeneous subtypes of non-Hodgkin lymphoma (NHL). With the exception of brentuximab (BV) with cyclophosphamide, adriamycin, prednisone (CHP) in anaplastic large cell lymphoma (ALCL) establishing a standard
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a91cb930c297b23ef81adff313288987
https://doi.org/10.1182/blood-2021-151238
https://doi.org/10.1182/blood-2021-151238
Autor:
Maximilian Stahl, Steven D. Gore, Kristen Roche, Nikolai A. Podoltsev, Kejal Amin, Stephanie Kasberg, Tae Kon Kim, Mina L. Xu, Lisa Barbarotta, Amer M. Zeidan, Thomas Prebet
Publikováno v:
Annals of Hematology. 95:1895-1898
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53eea6329a95c075f2c87c2cdee7a19d
https://doi.org/10.1007/s00277-016-2761-4
https://doi.org/10.1007/s00277-016-2761-4
Autor:
Kejal Amin, Jeffrey E Topal, Sarah Perreault, Maricar Malinis, Dayna McManus, Michelle Nadeau Nguyen, Stephen James Daleo
Publikováno v:
Open Forum Infectious Diseases
Background The Infectious Diseases Society of America and the National Comprehensive Cancer Network guidelines recommend adding vancomycin to the empiric treatment of NF in patients meeting specific criteria. After 48 hours, the guidelines recommend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fa4f4ad6c75e34939f495bad8b4f12f
https://doi.org/10.1093/ofid/ofx163.1271
https://doi.org/10.1093/ofid/ofx163.1271